Ma D - Search Results

Year	Number of Results
1952	1
1957	1
1960	1
1972	1
1973	1
1974	1
1976	1
1979	2
1980	2
1981	4
1982	11
1983	11
1984	15
1985	12
1986	11
1987	15
1988	13
1989	9
1990	11
1991	5
1992	11
1993	20
1994	27
1995	24
1996	28
1997	30
1998	44
1999	49
2000	42
2001	51
2002	71
2003	102
2004	97
2005	143
2006	147
2007	155
2008	184
2009	243
2010	266
2011	272
2012	332
2013	387
2014	448
2015	473
2016	531
2017	571
2018	649
2019	648
2020	770
2021	875
2022	968
2023	914
2024	1075
2025	945
2026	2

1

Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J, Zhou YF, Fu T, Lin CJ, Dai LJ, Liu CL, Zhao S, Su GH, Hou W, Liu Y, Chen Q, Yang J, Zhang N, Zhang WJ, Liu W, Ge W, Yang WT, You C, Gu Y, Kaklamani V, Bertucci F, Verschraegen C, Daemen A, Shah NM, Wang T, Guo T, Shi L, Perou CM, Zheng Y, Huang W, Shao ZM. Jiang YZ, et al. Among authors: ma d. Nat Cancer. 2024 Apr;5(4):673-690. doi: 10.1038/s43018-024-00725-0. Epub 2024 Feb 12. Nat Cancer. 2024. PMID: 38347143

2

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer.

Ma D, Dai LJ, Wu XR, Liu CL, Zhao S, Zhang H, Chen L, Xiao Y, Li M, Zhao YZ, Yang L, Zhou T, Li JJ, Yang WT, Jiang YZ, Shao ZM. Ma D, et al. Cancer Cell. 2025 Jun 9;43(6):1061-1075.e7. doi: 10.1016/j.ccell.2025.03.017. Epub 2025 Apr 10. Cancer Cell. 2025. PMID: 40215979 Clinical Trial.

3

Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial.

Wu SY, Jin X, Liu Y, Wang ZY, Zuo WJ, Ma D, Xiao Y, Fu T, Xiao YL, Chen L, Liu XY, Fan L, Wang ZH, Shen M, Liu R, Chai WJ, Shao ZM, Jiang YZ. Wu SY, et al. Among authors: ma d. Nat Med. 2025 Jul;31(7):2405-2415. doi: 10.1038/s41591-025-03776-7. Epub 2025 Jun 25. Nat Med. 2025. PMID: 40563015 Clinical Trial.

4

De novo design of transmembrane fluorescence-activating proteins.

Zhu J, Liang M, Sun K, Wei Y, Guo R, Zhang L, Shi J, Ma D, Hu Q, Huang G, Lu P. Zhu J, et al. Among authors: ma d. Nature. 2025 Apr;640(8057):249-257. doi: 10.1038/s41586-025-08598-8. Epub 2025 Feb 19. Nature. 2025. PMID: 39972138

5

Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia: A Randomized Clinical Trial.

Cao K, Tian L, Ma DL, Zhao SQ, Li A, Jin ZB, Jie Y. Cao K, et al. Among authors: ma dl. JAMA Ophthalmol. 2024 Jun 1;142(6):560-567. doi: 10.1001/jamaophthalmol.2024.0801. JAMA Ophthalmol. 2024. PMID: 38662345 Free PMC article. Clinical Trial.

6

Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells.

He X, Hu B, Zhang Y, Liu F, Li Q, Zheng C, Shen J, Yang Z, Wang J, Ma D, Qian C, Lu M, Mao J. He X, et al. Among authors: ma d. Autoimmun Rev. 2025 Jan 3;24(1):103692. doi: 10.1016/j.autrev.2024.103692. Epub 2024 Nov 17. Autoimmun Rev. 2025. PMID: 39561867

7

Embracing more treatment choices for metastatic, recurrent, or persistent cervical cancer.

Sun C, Ma D. Sun C, et al. Among authors: ma d. Lancet. 2024 Oct 26;404(10463):1618-1620. doi: 10.1016/S0140-6736(24)02196-2. Epub 2024 Oct 16. Lancet. 2024. PMID: 39426384 No abstract available.

8

Glymphatic inhibition exacerbates tau propagation in an Alzheimer's disease model.

Lopes DM, Wells JA, Ma D, Wallis L, Park D, Llewellyn SK, Ahmed Z, Lythgoe MF, Harrison IF. Lopes DM, et al. Among authors: ma d. Alzheimers Res Ther. 2024 Apr 5;16(1):71. doi: 10.1186/s13195-024-01439-2. Alzheimers Res Ther. 2024. PMID: 38576025 Free PMC article.

9

Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway.

Liu WC, Wei YH, Chen JF, Xing XL, Jia HX, Yang XY, Huang YJ, Liu XM, Xiao K, Guo XD, Can C, Zhang AM, He N, Zhang HL, Ma DX. Liu WC, et al. Among authors: ma dx. Nat Commun. 2025 Jun 3;16(1):5154. doi: 10.1038/s41467-025-60293-4. Nat Commun. 2025. PMID: 40461504 Free PMC article.

10

Targeting miR-337 mitigates disuse-induced bone loss.

Li J, Ma D, Zhang C, Zheng X, Hao R, Zuo B, Xiao F, Li Y, Liu Y, Duan Z, Xiong Y, Fan OR, Zhu W, Dai L, Zhang B, Sun YE, Zhang X. Li J, et al. Among authors: ma d. Cell Discov. 2025 Aug 26;11(1):71. doi: 10.1038/s41421-025-00822-z. Cell Discov. 2025. PMID: 40854881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,561 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,561 results

Results by year